ImageneBio IMA
NASDAQ IMA
$4.95 -0.06 (-1.20%)
As of: Sep 10, 2026 · 3:59 PM EDT

ImageneBio (IMA) Net Shares Issued and Repurchased (2021 - 2025)

ImageneBio's (IMA) quarterly Net Shares Issued and Repurchased came in at $1.1 million in Q1 2025, down 37.95% year-over-year from $1.8 million in Q1 2024, and down 52.11% quarter-over-quarter from $2.4 million in Q4 2024.

Analysis

ImageneBio (IMA) Net Shares Issued and Repurchased (2021 - 2025) Analysis & Trends

ImageneBio has disclosed Net Shares Issued and Repurchased across 5 years of filings, most recently posting $1.1 million for Q1 2025.

  • In Q1 2025, Net Shares Issued and Repurchased fell 37.95% year-over-year to $1.1 million; the TTM figure through Mar 2025 stood at $1.1 million (down 37.95% YoY), while the FY2024 annual figure was $2.4 million, up 35.82% from the prior year.
  • Net Shares Issued and Repurchased came in at $1.1 million for Q1 2025 at ImageneBio, down from $2.4 million in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $3.4 million in Q4 2021 to a low of $876524.0 in Q1 2022.
  • Average Net Shares Issued and Repurchased over 5 years is $1.9 million, with a median of $1.8 million recorded in 2024.
  • Year-over-year, Net Shares Issued and Repurchased sank 63.08% in 2022 and jumped 56.41% in 2023.
  • Over 5 years, Net Shares Issued and Repurchased stood at $3.4 million in 2021, then tumbled by 43.89% to $1.9 million in 2022, then fell by 9.2% to $1.8 million in 2023, then soared by 35.82% to $2.4 million in 2024, then slumped by 52.11% to $1.1 million in 2025.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.1 million in Q1 2025, $2.4 million in Q4 2024, and $1.8 million in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 ImageneBio 42.89 Mn -92.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.14 Mn
Dec 31, 2024 2.38 Mn
Mar 31, 2024 1.83 Mn
Dec 31, 2023 1.75 Mn
Mar 31, 2023 1.37 Mn
Dec 31, 2022 1.93 Mn
Mar 31, 2022 876,524.00
Dec 31, 2021 3.44 Mn
Mar 31, 2021 2.37 Mn